Bold integration of biomedical and behavioral science will result in successful HIV Prevention. Our Prevention Core leadership includes Co-Directors Michelle Lally, MD, MSc and Larry Brown, MD. With a shared passion for HIV prevention and a shared vision of novel "biobehavioral" approaches to HIV prevention. Dr. Lally investigates HIV Vaccines and PrEP, and Dr. Brown's extensive experience and expertise is in behavioral science. Additional Core Faculty, all superb and each committed to the combination of biomedical and behavioral science, include Michael Carey, PhD, Director of Centers for Behavioral and Preventive Medicine at Lifespan, Don Operario, PhD, Director of Graduate Program in Behavioral and Social Sciences Intervention, Brown Program in Public Health, Kate Morrow, PhD (microbicide acceptability). Curt Beckwith, MD (HIV testing and treatment among prisoners and other marginalized populations), Steve Hong, MD (international HIV primary and secondary prevention), and Kenneth Mayer, MD (broad HIV prevention experience and expertise). A red ribbon imprinted with "B &B" is our Core's logo, which has been effective at promoting the Biomedical &Behavioral branding of our Prevention Core.
Our Aims are to provide HIV prevention researchers (students /junior investigators / experienced investigators) with consultation and mentorship, education and training, and support services that are consistently inclusive of both biomedical and behavioral science.
Aims will be achieved through effective advertising of our services, individual consultations and ongoing mentorship of junior investigators, education and training (on a weekly, monthly, quarterly, or annual basis), and community collaboration. Expected outcomes are sustained and increased funding for research related to HIV prevention among our investigators, continued growth in the number of Core users, increased frequency of use of Core services, and a steady increase in the number of individual prevention projects that clearly incorporate both biomedical and behavioral science. Outcomes will be tracked and measured, and adjustments will be made to our approaches as necessary to assure that outcomes are achieved.

Public Health Relevance

HIV is a preventable infection, and AIDS is a preventable disease;yet prevention success can be achieved only when effective biological products are combined with requisite behavioral methodologies. The Prevention Core proposes to strategically support HIV prevention efforts with a combination of biomedical and behavioral science through the provision of expert

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-RRS-A (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Miriam Hospital
United States
Zip Code
Peterson, James; Cota, Michelle; Gray, Holly et al. (2015) Technology use in linking criminal justice reentrants to HIV care in the community: a qualitative formative research study. J Health Commun 20:245-51
Livingston, Nicholas A; Oost, Kathryn M; Heck, Nicholas C et al. (2015) The role of personality in predicting drug and alcohol use among sexual minorities. Psychol Addict Behav 29:414-9
Genberg, Becky L; Lee, Yoojin; Rogers, William H et al. (2015) Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav 19:85-92
Larney, Sarah; Mahowald, Madeline K; Scharff, Nicholas et al. (2014) Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health 104:e69-74
Merchant, Roland C; Baird, Janette R; Liu, Tao et al. (2014) Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population. Acad Emerg Med 21:752-67
Flentje, Annesa; Heck, Nicholas C; Sorensen, James L (2014) Characteristics of transgender individuals entering substance abuse treatment. Addict Behav 39:969-75
Beckwith, Curt G; Larney, Sarah; Flanigan, Timothy P (2014) Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye? Clin Infect Dis 58:762-4
Jonas, Anna; Sumbi, Victor; Mwinga, Samson et al. (2014) HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance. PLoS One 9:e100539
Conrad, Selby M; Tolou-Shams, Marina; Rizzo, Christie J et al. (2014) Gender differences in recidivism rates for juvenile justice youth: the impact of sexual abuse. Law Hum Behav 38:305-14
Dourado, InĂªs; MacCarthy, Sarah; Lima, Carlos et al. (2014) What's pregnancy got to do with it? Late presentation to HIV/AIDS services in Northeastern Brazil. AIDS Care 26:1514-20

Showing the most recent 10 out of 369 publications